Clinical Trial Update: Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on the combination of Anlotinib hydrochloride capsules with TQB2450 for endometrial cancer, currently NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)
• TQB2450

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Endometrial Cancer | Phase 3 | Status: NOT_YET_RECRUITING